197A — TAUNS Laboratories Income Statement
0.000.00%
Last trade - 00:00- ¥51bn
- ¥50bn
- ¥16bn
- 26
- 42
- 50
- 30
Annual income statement for TAUNS Laboratories, fiscal year end - June 30th, JPY millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | JAS | JAS |
| Status: | Final | Final |
| Revenue | ||
| Total Revenue | 17,457 | 15,673 |
| Cost of Revenue | ||
| Gross Profit | 14,682 | 9,200 |
| Selling / General / Administrative Expenses | ||
| Depreciation and Amortization | ||
| Unusual Expense / Income | ||
| Other Operating Expenses | ||
| Total Operating Expenses | 9,502 | 11,005 |
| Operating Profit | 7,955 | 4,668 |
| Gain / Loss on Sale of Assets | ||
| Total Net Non Operating Interest Income / Expense | ||
| Other Net Non Operating Costs | ||
| Net Income Before Taxes | 7,976 | 4,655 |
| Provision for Income Taxes | ||
| Net Income After Taxes | 4,481 | 3,035 |
| Net Income Before Extraordinary Items | ||
| Net Income | 4,481 | 3,035 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||
| Income Available to Common Shareholders Including Extraordinary Items | ||
| Diluted Net Income | 4,481 | 3,035 |
| Diluted Weighted Average Shares | ||
| Basic EPS Including Extraordinary Items | ||
| Diluted EPS Including Extraordinary Items | ||
| Diluted EPS Excluding Extraordinary Items | ||
| Normalised Income Before Taxes | ||
| Normalised Income After Taxes | ||
| Normalised Income Available to Common Shareholders | ||
| Diluted Normalised EPS | 63 | 32.3 |
| Dividends per Share |